Reaffirming commitment to sustainability
As the pharma sector battles the COVID-19 pandemic and goes through a reset to defend the world against such crises in future, it…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Pharma sector reacts to Union Budget 2021
Adopting the paperless culture, the Finance Minister Nirmala Sitharaman presented the Union Budget 2021-22 which is considered as…
IGBA appoints Sudarshan Jain as Chair for 2021
He takes over from Hanan Sboul, Secretary-General of the Jordanian Association of Pharmaceutical Manufacturers
Covishield vaccine transport to commence from SII’s Pune facility on Jan 11 or 12: Sources
SII source had said that certain processes are being finalised about transportation of the vaccine
Indifi partners with Retailio, strengthening its presence in pharma
The partnership allows Indifi to cater to around 100,000 retailers already present on the Retailio platform.
Effective effluent management: Key to tackle AMR
Dr Jyoti Joshi, Head-South Asia, The Center for Disease Dynamics, Economics & Policy (CDDEP); Adjunct Professor, Amity…
GenNext at SIRO Clinpharm
SIRO, one of India’s earliest CROs, is set to scale new heights, as its next-gen leaders chart out fresh strategies to sustain its…
AstraZeneca signs MoU with RSSDI to empower one crore Indian Diabetic patients by 2023
Chronic kidney diseases is associated with significant patient death and an increased risk of heart failure. Therefore, it is…
Antibodies against SARS-CoV-2 wane over time, suggesting immunity may be short-lived: GlobalData
Following new data from Imperial College London (ICL) suggesting that antibody levels against SARS-CoV-2 wane over time; Michael…
Australia’s star vaccine maker not immune to virus anxiety: Analysis
while the coronavirus pandemic has lifted CSL Ltd's investment profile, virus anxieties are also hitting its most lucrative…
Preventing counterfeiting with global identification standard
S Swaminathan, COO, GS1 explains how adoption of global standards can bring enhanced efficiencies in the supply chain and benefit…
Global pharma’s two battles – supply continuity and COVID-19 vaccine
Richa Mahindru, Domain Leader, Pharma and Life Sciences Practice, and Ishani Jain, Member, Pharma and Life Sciences Practice…
Blueprint for self-reliance in the bio-pharma sector
Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals highlights that the COVID-19 crisis has opened a window of opportunity…
Navigating turbulent times
Industry stakeholders share their views and concerns about the challenges and impact of the coronavirus pandemic and the…
“GS1 India has been actively providing technical guidance and implementation support for the DAVA…
Ravi Mathur, CEO, GS1 India talks about GS1’s initiatives for the pharma sector and the impact its aims to create, in an exclusive…
Fortifying defence against zoonoses
Express Pharma series on the key pillars of a strategic framework to tackle zoonotic diseases
Coping with COVID-19: AGI glaspac
Dealing with hampered production and lack of input raw materials, AGI glaspac has put in measures to cushion the blow. For…
Reducing India’s Import Dependence on APIs: A possible way out
Reji K Joseph, Associate Professor at Institute for Studies in Industrial Development, New Delhi writes about how different bodies…
How Jan Aushadhi will change the game for pharma
Dr Vikram Munshi, Founder and Principal Consultant, Whitespace Consulting and Capability Building, evaluates the state of Jan…
Opportunity for Indian pharma industry to capitalise on escalating US-China trade war: GlobalData
Both China and the US are key markets for India from the pharma industry perspective It’s been more than a year since China and…